Association between serum lipase levels and chronic kidney disease stages
PLOS One · 18.08.2025 · 20 (8) · e0330329
DOI: 10.1371/journal.pone.0330329 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 18.08.2025. Verfasst von Gui Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Taizhou Hospital Shanghai University Traditional Chinese Medicine Taizhou City Traditional Chinese Medicine Hospit…. Hauptthemen laut MEDLINE: Lipase, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medicine and Health Science and Technology Plan Projects in Zhejiang Province.
Abstract (Originalsprache)
Objective
To explore the relationship between serum lipase levels and chronic kidney disease (CKD) progression, evaluating its usefulness in assessing efficacy, severity, and predicting outcomes in CKD.
Methods
This retrospective study analyzed 251 CKD patients treated at our hospital from January 2018 to December 2023, categorizing them into four groups based on 2022 Chinese and 2024 KDIGO guidelines. Clinical and biochemical data, including serum lipase, Scr, and BUN were collected. Additionally, a supplementary cohort of 50 CKD patients treated between January 2024 and March 2025 was included to support the findings.
Results
Serum lipase levels increased with advancing CKD stages [G1-2: 40.50 (30.75,52.00), G3:47.00 (37.25,61.00), G4:100.00 (77.00,126.00), G5:155.50 (126.75,243.75), (P < 0.05), showing a positive correlation with Scr (r = 0.714, P < 0.001) and BUN ((r = 0.678, P < 0.001). Univariate logistic regression analysis indicated that age, Scr, BUN, and serum lipase were positively associated with CKD stages, whereas HDL-C exhibited negative correlations. Multivariate logistic regression analysis identified several associated factors of CKD stages, including Scr (OR=1.01; 95% CI 1.01–1.02; P < 0.001), BUN (OR=1.17; 95% CI 1.07–1.29; P < 0.001), age (OR=1.03; 95% CI 1.01–1.05; P = 0.019), and serum lipase (OR=1.02, 95% CI 1.01–1.03, P < 0.001). Serum lipase’s AUC for distinguishing CKD stages G1-2 vs. G3, G3 vs. G4, and G4 vs. G5 were 0.64 (0.55–0.73), 0.89 (0.83–0.94), and 0.84 (0.75–0.93), respectively, with validation cohort AUCs of 0.65 (0.45–0.85), 0.82 (0.62–1.00), and 0.86 (0.65–1.00).
Conclusions
Serum lipase emerges as a novel biomarker for CKD stages, exhibiting stage-dependent increases and independent prognostic significance. Regular testing could improve risk assessment and complement current markers like eGFR and proteinuria, enhancing CKD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Taizhou Hospital Shanghai University Traditional Chinese Medicine Taizhou City Traditional Chinese Medicine Hospital, Taizhou, Zhejiang Province, China.
- Department of Clinical Laboratory, The People's Hospital of Cangnan Zhejiang, Wenzhou, Zhejiang Province, China.
- Department of Clinical Laboratory, Linhai Second People's Hospital, Linhai, Zhejiang, Province, China.
ORCID-Profile: Cheng Xin Xu
Förderung
- Medicine and Health Science and Technology Plan Projects in Zhejiang Province
Zitieren
APA
Zhang, G., Li, Z., & Xu, C. X. (2025). Association between serum lipase levels and chronic kidney disease stages. PLOS One, 20(8), e0330329. https://doi.org/10.1371/journal.pone.0330329
Vancouver
Zhang G, Li Z, Xu CX. Association between serum lipase levels and chronic kidney disease stages. PLOS One. 2025;20(8):e0330329. doi:10.1371/journal.pone.0330329
BibTeX
@article{Zhang2025,
author = {Zhang, Gui and Li, Zuojie and Xu, Cheng Xin},
title = {Association between serum lipase levels and chronic kidney disease stages},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {8},
pages = {e0330329},
doi = {10.1371/journal.pone.0330329}
}
EUVIMED